Clinicopathological analysis of PD-L2 expression in colorectal cancer

BACKGROUND: (PD-L2), a ligand of programmed cell death protein 1 (PD-1), is an inhibitory receptor of T cells and activated B cells. Many studies have focused on PD-L1, another ligand of PD-1, and the prognostic significance of PD-L1 has been reported in many tumors. However, the expression of PD-L2...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Peng-Da, Sun, Zhong-Wen, Lai, Hui-Jun, Yang, Jie, Wu, Ping-Ping, Guo, Yun-Di, Sun, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219115/
https://www.ncbi.nlm.nih.gov/pubmed/30464512
http://dx.doi.org/10.2147/OTT.S177329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219115/
https://www.ncbi.nlm.nih.gov/pubmed/30464512
http://dx.doi.org/10.2147/OTT.S177329

Ejemplares similares